Clovis Oncology (CLVS) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for CLVS stock
Clovis Oncology, Inc. Analysis
CLVS Stock News


Popular stocks
Vale S.A.
NVIDIA
Boeing
GameStop
TAL Education
Shopify
Alibaba
Tesla
Genprex
Microsoft

TOP Stocks
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
Visionary Holdings
Digital World Acquisition
Amyris
KAR Auction Services
VMware
Ocuphire Pharma
Verizon
Nabors Industries
Abiomed
Tyson Foods


Financial News

Popular Stocks Analysis

Investor's Journal
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…
  1. Home
    2. »
  2. Stock forecasts
    3. »
  3. CLVS

Clovis Oncology (CLVS) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: April 18, 2025 (00:14)

Sector: Healthcare

The share price of Clovis Oncology, Inc. (CLVS) now

This company is DELISTED
Latest session on the 17th of April for
Clovis Oncology, Inc. is negative
Trading Volume:
Open: 0 /  High: 0 /  Low: 0

Are you interested in Clovis Oncology, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Clovis Oncology stock price in 2025, 2026, 2027. How much will one Clovis Oncology share be worth in 2025 - 2027?

When should I take profit in Clovis Oncology stock? When should I record a loss on Clovis Oncology stock? What are analysts' forecasts for Clovis Oncology stock? What is the future of Clovis Oncology stock? We forecast Clovis Oncology stock performance using neural networks based on historical data on Clovis Oncology stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Clovis Oncology stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Clovis Oncology shares. This happens once a day.


Historical and forecast chart of Clovis Oncology stock

The chart below shows the historical price of Clovis Oncology stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Clovis Oncology stock price can be found in the table below.

No data

Long-term forecasts by years.

Clovis Oncology, Inc., a biopharmaceutical company, specializes in the acquisition, development and commercialization of anti-cancer agents in the United States, the European Union and internationally. The company offers Rubraca (rucaparib), an oral small molecule poly-ADP-ribose polymerase inhibitor for the treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Trending Themes in the Healthcare Sector

Clovis Oncology daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 19 0.08 0.08 0.09 4.89
Apr 20 0.08 0.08 0.09 7.45
Apr 21 0.08 0.08 0.08 6.04
Apr 22 0.08 0.08 0.08 3.17
Apr 23 0.08 0.08 0.08 7.06
Apr 24 0.08 0.08 0.08 5.03
Apr 25 0.08 0.08 0.08 4.62
Apr 26 0.08 0.08 0.08 6.20
Apr 27 0.09 0.08 0.09 7.31
Apr 28 0.08 0.08 0.09 6.67
Apr 29 0.08 0.08 0.08 5.48
Apr 30 0.08 0.08 0.08 6.03
May 01 0.08 0.07 0.08 6.60
May 02 0.08 0.08 0.08 7.04
May 03 0.08 0.08 0.08 6.88
May 04 0.08 0.08 0.09 4.09
May 05 0.08 0.08 0.09 6.58
May 06 0.08 0.08 0.09 5.71
May 07 0.08 0.08 0.08 9.83
May 08 0.08 0.08 0.08 6.84
May 09 0.08 0.08 0.08 4.34
May 10 0.07 0.07 0.08 7.96
May 11 0.07 0.07 0.08 6.13
May 12 0.07 0.07 0.08 7.78
May 13 0.08 0.07 0.08 5.89
May 14 0.08 0.07 0.08 6.42
May 15 0.07 0.07 0.08 6.26
May 16 0.08 0.07 0.08 5.81
May 17 0.08 0.07 0.08 8.05
May 18 0.08 0.08 0.08 5.14

Clovis Oncology Daily Price Targets


Clovis Oncology Stock Forecast 04-19-2025.

Forecast target price for 04-19-2025: $0.08.
Positive dynamics for Clovis Oncology shares will prevail with possible volatility of 4.660%.
Pessimistic target level: 0.08
Optimistic target level: 0.09

Clovis Oncology Stock Forecast 04-20-2025.

Forecast target price for 04-20-2025: $0.08.
Negative dynamics for Clovis Oncology shares will prevail with possible volatility of 6.932%.
Pessimistic target level: 0.08
Optimistic target level: 0.09

Clovis Oncology Stock Forecast 04-21-2025.

Forecast target price for 04-21-2025: $0.08.
Negative dynamics for Clovis Oncology shares will prevail with possible volatility of 5.692%.
Pessimistic target level: 0.08
Optimistic target level: 0.08

Clovis Oncology Stock Forecast 04-22-2025.

Forecast target price for 04-22-2025: $0.08.
Positive dynamics for Clovis Oncology shares will prevail with possible volatility of 3.072%.
Pessimistic target level: 0.08
Optimistic target level: 0.08

Clovis Oncology Stock Forecast 04-23-2025.

Forecast target price for 04-23-2025: $0.08.
Positive dynamics for Clovis Oncology shares will prevail with possible volatility of 6.595%.
Pessimistic target level: 0.08
Optimistic target level: 0.08

Clovis Oncology Stock Forecast 04-24-2025.

Forecast target price for 04-24-2025: $0.08.
Positive dynamics for Clovis Oncology shares will prevail with possible volatility of 4.785%.
Pessimistic target level: 0.08
Optimistic target level: 0.08

CLVS (CLVS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
May. 0.10 0.08 0.12 27.16
Jun. 0.12 0.11 0.13 18.43
Jul. 0.11 0.10 0.13 19.02
Aug. 0.11 0.10 0.13 19.30
Sep. 0.09 0.07 0.11 31.44
Oct. 0.08 0.07 0.10 26.71
Nov. 0.09 0.08 0.10 16.45
Dec. 0.09 0.08 0.10 22.71
Full forecast for 2025

Clovis Oncology forecast for this year


Clovis Oncology Stock Prediction for May 2025

An uptrend is forecast for this month with an optimal target price of $0.0962058. Pessimistic: $0.08. Optimistic: $0.12


Clovis Oncology Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $0.121258. Pessimistic: $0.11. Optimistic: $0.13


Clovis Oncology Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $0.111751. Pessimistic: $0.10. Optimistic: $0.13


Clovis Oncology Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $0.111751. Pessimistic: $0.10. Optimistic: $0.13


Clovis Oncology Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $0.092664. Pessimistic: $0.07. Optimistic: $0.11


Clovis Oncology Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $0.0841019. Pessimistic: $0.07. Optimistic: $0.10


Clovis Oncology Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $0.0859858. Pessimistic: $0.08. Optimistic: $0.10


Clovis Oncology Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $0.0888749. Pessimistic: $0.08. Optimistic: $0.10



Clovis Oncology (CLVS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.08 0.07 0.09 19.59
Feb 0.06 0.06 0.07 21.98
Mar 0.07 0.06 0.07 16.96
Apr 0.07 0.07 0.08 16.49
May 0.07 0.06 0.08 25.49
Jun 0.07 0.07 0.09 26.23
Jul 0.10 0.08 0.11 28.63
Aug 0.12 0.09 0.13 30.53
Sep 0.12 0.11 0.15 27.48
Oct 0.16 0.15 0.17 15.16
Nov 0.17 0.15 0.19 20.53
Dec 0.12 0.10 0.15 31.83
Full forecast for 2026

Clovis Oncology (CLVS) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 0.13 0.11 0.15 23.73
Feb 0.13 0.12 0.16 23.89
Mar 0.13 0.11 0.15 28.21
Apr 0.14 0.13 0.16 17.48
May 0.13 0.11 0.15 26.10
Jun 0.14 0.13 0.15 12.79
Jul 0.15 0.14 0.17 19.27
Aug 0.13 0.11 0.15 27.31
Sep 0.12 0.10 0.14 29.75
Oct 0.13 0.12 0.15 23.02
Nov 0.11 0.10 0.14 27.77
Dec 0.13 0.11 0.16 30.49
Full forecast for 2027

Clovis Oncology information and performance

Clovis Oncology Address

N/A

Market Capitalization: N/A $

Market capitalization of the Clovis Oncology, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CLVS shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Clovis Oncology is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Clovis Oncology Stock)

Should I Buy Clovis Oncology Shares in 2025 year?

The maximum forecasted share price for next year is $0.17, which is $0.09 higher than the current stock price. By investing in Clovis Oncology shares today for a one-year period, you could achieve a profit of 107.31%. With an investment horizon of up to two years, the target share price is $0.15. resulting in a profit of 82.11% ($0.07 per share).

Does Clovis Oncology pay dividends?

No, it does not

Which economic sector do Clovis Oncology's shares belong to?

Clovis Oncology's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Clovis Oncology's shares?

You can view all the stocks that are part of the same sector as Clovis Oncology's shares in the Healthcare section.


Related stocks from Healthcare sector

Bright Green Corporation (BGXX)
Galera Therapeutics, Inc. (GRTX)
Turning Point Therapeutics, Inc. (TPTX)
Lipella Pharmaceuticals Inc. (LIPO)
Ensysce Biosciences, Inc. (ENSC)
Alnylam Pharmaceuticals, Inc. (ALNY)
Longeveron Inc. (LGVN)
Vaccinex, Inc. (VCNX)
Immuron Limited (IMRN)
Novartis AG (NVS)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.